FDA To Quiz Prescribers On Opioid Promotion
The U.S. Food and Drug Administration on Friday said it will survey 2,000 prescribers for insights into drugmakers' promotional efforts, including opioid promotions that have fueled staggering amounts of litigation....To view the full article, register now.
Already a subscriber? Click here to view full article